Literature DB >> 29172590

The mediating effect of family cohesion in reducing patient symptoms and family distress in a culturally informed family therapy for schizophrenia: A parallel-process latent-growth model.

Caitlin A Brown1, Amy Weisman de Mamani1.   

Abstract

OBJECTIVE: Although both patients with schizophrenia and their caregivers report elevated levels of depression, anxiety, and stress (DASS), affective symptoms in patients and family members seldom constitute a primary treatment focus. The present study tested whether a culturally informed family therapy for schizophrenia (CIT-S) outperformed standard family psychoeducation (PSY-ED) not only in decreasing patient schizophrenia symptoms, but also in decreasing individual DASS. Because CIT-S fostered family cohesion throughout treatment, we predicted that increases in family cohesion would mediate treatment effects.
METHOD: Participants included 266 patients and family members nested within 115 families, randomized to the CIT-S or PSY-ED conditions. We specified a series of multilevel latent growth and latent change models to examine direct effects of CIT-S on patient schizophrenia symptoms, individual DASS, and family cohesion over time. Next, we used parallel-process growth models to test the indirect effect of CIT-S on decreasing patient and caregiver psychopathology over time via changes in family cohesion.
RESULTS: The CIT-S treatment significantly reduced patient schizophrenia symptoms from baseline to follow-up (γ = -1.72, 95% confidence interval [CI] [-2.83, -0.60]), as well as individual DASS (γ = -4.39, 95% CI [-6.44, -2.34]) from baseline to termination. In line with treatment goals, CIT-S increased family cohesion from baseline to midpoint (γ = 0.93, 95% CI [0.06, 1.80]). The CIT-S-related change in cohesion mediated changes in DASS (γ = -0.87, 95% CI [-1.47, -0.27]), but not patient symptoms.
CONCLUSION: By integrating the family's cultural context into treatment, clinicians may foster family dynamics that enhance treatment outcomes and promote broad improvements in mental health. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 29172590      PMCID: PMC5754235          DOI: 10.1037/ccp0000257

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  36 in total

1.  Ethnicity, expressed emotion, attributions, and course of schizophrenia: family warmth matters.

Authors:  Steven Regeser López; Kathleen Nelson Hipke; Antonio J Polo; Janis H Jenkins; Marvin Karno; Christine Vaughn; Karen S Snyder
Journal:  J Abnorm Psychol       Date:  2004-08

Review 2.  Latent variable modeling of differences and changes with longitudinal data.

Authors:  John J McArdle
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

3.  Investigation of Mediational Processes Using Parallel Process Latent Growth Curve Modeling.

Authors:  Jeewon Cheong; David P Mackinnon; Siek Toon Khoo
Journal:  Struct Equ Modeling       Date:  2003-04-01       Impact factor: 6.125

4.  Confidence interval estimation for standardized effect sizes in multilevel and latent growth modeling.

Authors:  Alan Feingold
Journal:  J Consult Clin Psychol       Date:  2014-09-01

5.  A Regression Framework for Effect Size Assessments in Longitudinal Modeling of Group Differences.

Authors:  Alan Feingold
Journal:  Rev Gen Psychol       Date:  2013-03

6.  Psychoeducation in schizophrenia--results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland.

Authors:  Christine Rummel-Kluge; Gabriele Pitschel-Walz; Josef Bäuml; Werner Kissling
Journal:  Schizophr Bull       Date:  2006-07-14       Impact factor: 9.306

7.  Symptom monitoring in the rehabilitation of schizophrenic patients.

Authors:  D Lukoff; R P Liberman; K H Nuechterlein
Journal:  Schizophr Bull       Date:  1986       Impact factor: 9.306

8.  Burden, interdependence, ethnicity, and mental health in caregivers of patients with schizophrenia.

Authors:  Giulia Suro; Amy G Weisman de Mamani
Journal:  Fam Process       Date:  2012-10-18

Review 9.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

10.  A randomized clinical trial to test the efficacy of a family-focused, culturally informed therapy for schizophrenia.

Authors:  Amy Weisman de Mamani; Marc J Weintraub; Kayla Gurak; Jessica Maura
Journal:  J Fam Psychol       Date:  2014-10-06
View more
  1 in total

1.  Effects of family intervention on psychosocial functioning and mood symptoms of youth at high risk for bipolar disorder.

Authors:  Marc J Weintraub; Christopher D Schneck; Filippo Posta; John A Merranko; Manpreet K Singh; Kiki D Chang; David J Miklowitz
Journal:  J Consult Clin Psychol       Date:  2022-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.